$43.120
-1.233 (-2.86%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
VCYT Prediction & Forecast by Similar Chart Analysis
Alphio's VCYT stock price prediction model matches the current Veracyte Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $43.63 (+1.18%). The 1-week path is $46.30 (+7.37%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Veracyte Inc Stock?
Veracyte Inc (VCYT) is a good buy right now, trading at $43.12 with a forward P/E of 23.58, suggesting potential for growth. The recent Medicare coverage for its Prosigna test is a significant positive catalyst, likely to enhance revenue streams. However, the RSI is at 42.24, indicating it is near the oversold territory, which could present a buying opportunity. The main risk is the recent downgrade from Morgan Stanley, which set a lower price target of $44, indicating potential downside.
VCYT stock price ended at $43.12 on Friday, after losing -2.86%
Veracyte Inc (VCYT) last closed at $43.12, losing -2.86%. These facts feed the 1-day and 1-week VCYT price prediction above.
Analyst Consensus
Veracyte Inc (VCYT): 4 buy, 2 hold, 0 sell. Outlook: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Veracyte Inc (VCYT) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches VCYT, ranked by similarity.
Seasonality analysis for VCYT
Historically the probability of a positive October return for VCYT is 60.34%. December offers the highest probability of a positive month at 100.00%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for VCYT
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $27.18 | $29.86 | $33.35 | -30.76% |
| Nov 2026 | $28.05 | $35.61 | $35.97 | -17.41% |
| Dec 2026 | $28.37 | $36.96 | $40.95 | -14.29% |
In 2026, Veracyte Inc (VCYT) is projected to range from $27.18 to $40.95.
Veracyte Inc 2026 monthly forecast
In Oct 2026, Veracyte Inc is projected to average $29.86, with a low of $27.18 and high of $33.35.
In Nov 2026, Veracyte Inc is projected to average $35.61, with a low of $28.05 and high of $35.97.
In Dec 2026, Veracyte Inc is projected to average $36.96, with a low of $28.37 and high of $40.95.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.